CNS Pharmaceuticals, Inc. - Common Stock (CNSP) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
CNSP on Nasdaq
Shares outstanding
575,357
Price per share
$5.45
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
24,616
Total reported value
$221,544
% of total 13F portfolios
0%
Share change
+24,603
Value change
+$221,533
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CNS Pharmaceuticals, Inc. - Common Stock (CNSP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 5.6% $289,980 32,220 Stonepine Capital Management, LLC 29 Oct 2025

As of 30 Sep 2025, 8 institutional investors reported holding 24,616 shares of CNS Pharmaceuticals, Inc. - Common Stock (CNSP). This represents 4.3% of the company’s total 575,357 outstanding shares.

Institutional Holders of CNS Pharmaceuticals, Inc. - Common Stock (CNSP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 24,616 $221,544 +$221,533 $9.00 8
2025 Q2 13 $11 +$11 $0.85 1